Drug composition for treating cerebral thrombosis

A composition and technology of cerebral thrombosis, applied in the field of western medicine, can solve the problems of slow curative effect and large side effects, and achieve fast curative effect

Inactive Publication Date: 2017-05-17
ZHENGZHOU ZHENGXIAN PHARMA CO LTD
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, Western medicines for treating cerebral thrombosis mainly include vasodilators, antihypertensive dr

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] In an embodiment of the present invention, a pharmaceutical composition for treating cerebral thrombosis, the active ingredient is composed of 0.15 parts of crocin, 2.0 parts of acetyl midecamycin, and 0.35 parts of eriodictine in the following parts by mass.

Embodiment 2

[0019] In an embodiment of the present invention, a pharmaceutical composition for treating cerebral thrombosis, the active ingredient is composed of 0.18 parts of crocetin, 1.6 parts of acetyl midecamycin, and 0.42 parts of eriodictin in the following parts by mass.

Embodiment 3

[0021] In an embodiment of the present invention, a pharmaceutical composition for treating cerebral thrombosis, the active ingredient is composed of 0.16 parts of crocin, 1.9 parts of acetyl midecamycin, and 0.37 parts of eriodictin in the following parts by mass.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a drug composition for treating cerebral thrombosis; the active components of the drug composition mainly comprise, by mass, 0.10-0.20 part of picrocrocin, 1.6-2.0 parts of midecamycin acetate, 0.35-0.42 parts of North America eriodictyol; the adult drug dosage is 240-260 mg active component/kg/day. The drug composition has the effects of clearing heat and promoting diuresis, invigorating the circulation of blood and detoxifying, and dispelling wind and removing obstruction in the meridians; the composition is featured by quick treatment effect and no relapse after curing specific to dizziness, nausea, sickness, diplopia, crossed akinesia and sensory disturbance, dysarthria, dysphagia, drinking choke and other symptoms caused by treating cerebral thrombosis; after long-term taking, the composition is free from obvious damage to liver and kidney, and worthy of extensive popularization and application clinically.

Description

technical field [0001] The invention relates to the field of western medicine, in particular to a pharmaceutical composition for treating cerebral thrombosis. Background technique [0002] Cerebral thrombosis is the most common type of cerebral infarction. It is the thickening of blood vessels, stenosis and occlusion of the lumen caused by atherosclerosis of the cerebral artery trunk or cortical branches, and thrombosis, resulting in reduced or interrupted blood flow in the brain, cerebral ischemia and ischemia. Oxygen leads to softening and necrosis, with signs of focal neurologic symptoms. The onset of cerebral thrombosis is generally slow, and it takes dozens of hours to several days from the onset to the peak of the disease. This disease often occurs during sleep or when resting quietly; some patients often do not have any aura symptoms before going to bed. Hemiplegia or aphasia is found when waking up, which may be related to low blood pressure and slow blood flow duri...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/7034A61K31/7048A61K31/352A61P7/02A61P9/10
CPCA61K31/7034A61K31/352A61K31/7048A61K2300/00
Inventor 不公告发明人
Owner ZHENGZHOU ZHENGXIAN PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap